NL-OMON43667
Completed
Not Applicable
Age-related changes of the immune system leading to hyporesponsiveness; a major player and predictor for biological behaviour of metastasized melanoma? - Aging immune system in melanoma patients.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- metastasized melanoma
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 30
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\> 18 years of age
- •informed consent
- •metastasized melanoma
- •After treatment
Exclusion Criteria
- •severe anemia (Hb \< 6\.0\)
- •concomitant chronic diseases that may affect immune system
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
De rol van veroudering van het immuunsysteem bij het melanoom.NL-OMON22761MCG30
Recruiting
Not Applicable
Analyzing the impact of aging on the immune system in the context of covid-19 vaccinatioCOVID-19JPRN-jRCT1050210014Hamazaki Yoko200
Completed
Not Applicable
Immune ageing in health and diseasegezonde veroudering en ongezonde veroudering/frailtyageing and frailtyNL-OMON39532niversitair Medisch Centrum Groningen300
Completed
Not Applicable
Exploratory study into age-related immunological differences related to immunogenicity in influenza vaccination and herpes zoster vaccinatioNL-OMON50860Radboud Universitair Medisch Centrum147
Active, not recruiting
Phase 1
Age differences in flu and shingles vaccine responseInfluenza Herpes ZosterTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-005682-13-NLRadboudumc140